DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 4.89% to $0.97 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.46% to 51,947.25 and the NASDAQ Composite Index falling 0.64% to 24,975.82.
This was the stock's third consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 67.43% below its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.59% to $263.40, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.16% to $24.54.
Trading volume (3.7 M) eclipsed its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 24, 2026 17:26 ET (21:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.